Nanhua Bio Medicine Stock Annual Yield
| 000504 Stock | 10.50 0.07 0.66% |
Nanhua Bio Medicine fundamentals help investors to digest information that contributes to Nanhua Bio's financial success or failures. It also enables traders to predict the movement of Nanhua Stock. The fundamental analysis module provides a way to measure Nanhua Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanhua Bio stock.
Nanhua | Annual Yield |
Nanhua Bio Medicine Company Annual Yield Analysis
Nanhua Bio's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Nanhua Bio Medicine has an Annual Yield of 0.0%. This indicator is about the same for the Media average (which is currently at 0.0) sector and about the same as Communication Services (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Nanhua Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanhua Bio's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanhua Bio could also be used in its relative valuation, which is a method of valuing Nanhua Bio by comparing valuation metrics of similar companies.Nanhua Bio is currently under evaluation in annual yield category among its peers.
Nanhua Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0455 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 3.2 B | ||||
| Shares Outstanding | 330.02 M | ||||
| Shares Owned By Insiders | 13.01 % | ||||
| Shares Owned By Institutions | 40.52 % | ||||
| Price To Book | 13.94 X | ||||
| Price To Sales | 27.84 X | ||||
| Revenue | 136.79 M | ||||
| Gross Profit | 127.36 M | ||||
| EBITDA | (38.19 M) | ||||
| Net Income | (28.17 M) | ||||
| Total Debt | 28.12 M | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | 36.28 M | ||||
| Earnings Per Share | (0.12) X | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 3.49 B | ||||
| Total Asset | 771.38 M | ||||
| Retained Earnings | (531.1 M) | ||||
| Working Capital | 202.45 M | ||||
| Net Asset | 771.38 M |
About Nanhua Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanhua Bio Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanhua Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanhua Bio Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.